{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T17:10:07Z","timestamp":1795108207719,"version":"4.10.3"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,29]],"date-time":"2022-10-29T00:00:00Z","timestamp":1667001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,29]],"date-time":"2022-10-29T00:00:00Z","timestamp":1667001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Anti-melanoma differentiation-associated gene 5-positive dermatomyositis (MDA5\n                    <jats:sup>+<\/jats:sup>\n                    DM) is an autoimmune condition associated with rapidly progressive interstitial lung disease and high mortality. The aetiology and pathogenesis of MDA5\n                    <jats:sup>+<\/jats:sup>\n                    DM are still largely unknown. Here we describe the immune signatures of MDA5\n                    <jats:sup>+<\/jats:sup>\n                    DM via single-cell RNA sequencing, flow cytometry and multiplex immunohistochemistry in peripheral B and T cells and in affected lung tissue samples from one patient. We find strong peripheral antibody-secreting cell and CD8\n                    <jats:sup>+<\/jats:sup>\n                    T cell responses as cellular immune hallmarks, and over-stimulated type I interferon signaling and associated metabolic reprogramming as molecular immune signature in MDA5\n                    <jats:sup>+<\/jats:sup>\n                    DM. High frequency of circulating ISG15\n                    <jats:sup>+<\/jats:sup>\n                    CD8\n                    <jats:sup>+<\/jats:sup>\n                    T cells at baseline predicts poor one-year survival in MDA5\n                    <jats:sup>+<\/jats:sup>\n                    DM patients. In affected lungs, we find profuse immune cells infiltration, which likely contributes to the pro-fibrotic response via type I interferon production. The importance of type I interferons in MDA5\n                    <jats:sup>+<\/jats:sup>\n                    DM pathology is further emphasized by our observation in a retrospective cohort of MDA5\n                    <jats:sup>+<\/jats:sup>\n                    DM patients that combined calcineurin and Janus kinase inhibitor therapy show superior efficacy to calcineurin inhibitor monotherapy. In summary, this study reveals key immune-pathogenic features of MDA5\n                    <jats:sup>+<\/jats:sup>\n                    DM and provides a potential basis for future tailored therapies.\n                  <\/jats:p>","DOI":"10.1038\/s41467-022-34145-4","type":"journal-article","created":{"date-parts":[[2022,10,29]],"date-time":"2022-10-29T06:15:09Z","timestamp":1667024109000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":129,"title":["Single-cell profiling reveals distinct adaptive immune hallmarks in MDA5+ dermatomyositis with therapeutic implications"],"prefix":"10.1038","volume":"13","author":[{"given":"Yan","family":"Ye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4363-5949","authenticated-orcid":false,"given":"Zechuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengyun","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqiang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1498-7059","authenticated-orcid":false,"given":"Pei","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangjing","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5875-4417","authenticated-orcid":false,"given":"Nan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunde","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6732-9132","authenticated-orcid":false,"given":"Xiaoming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,29]]},"reference":[{"key":"34145_CR1","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1136\/annrheumdis-2017-211468","volume":"76","author":"IE Lundberg","year":"2017","unstructured":"Lundberg, I. E. et al. 2017 European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Ann. Rheum. Dis. 76, 1955\u20131964 (2017).","journal-title":"Ann. Rheum. Dis."},{"key":"34145_CR2","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/s41572-021-00321-x","volume":"7","author":"IE Lundberg","year":"2021","unstructured":"Lundberg, I. E. et al. Idiopathic inflammatory myopathies. Nat. Rev. Dis. Prim. 7, 86 (2021).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"34145_CR3","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.nmd.2019.10.005","volume":"30","author":"AL Mammen","year":"2020","unstructured":"Mammen, A. L., Allenbach, Y., Stenzel, W. & Benveniste, O., Group, E.t.W.S. 239th ENMC International Workshop: Classification of dermatomyositis, Amsterdam, the Netherlands, 14-16 December 2018. Neuromuscul. Disord. 30, 70\u201392 (2020).","journal-title":"Neuromuscul. Disord."},{"key":"34145_CR4","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s12016-020-08822-5","volume":"60","author":"W Wu","year":"2021","unstructured":"Wu, W. et al. Interstitial lung disease in anti-MDA5 positive dermatomyositis. Clin. Rev. Allergy Immunol. 60, 293\u2013304 (2021).","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"34145_CR5","doi-asserted-by":"publisher","first-page":"e70","DOI":"10.1212\/WNL.0000000000009727","volume":"95","author":"Y Allenbach","year":"2020","unstructured":"Allenbach, Y. et al. Different phenotypes in dermatomyositis associated with anti-MDA5 antibody: Study of 121 cases. Neurology 95, e70\u2013e78 (2020).","journal-title":"Neurology"},{"key":"34145_CR6","doi-asserted-by":"crossref","unstructured":"Giannini, M. et al. Similarities between COVID-19 and anti-MDA5 syndrome: what can we learn for better care? Eur. Respir. J. 56, 2001618 (2020).","DOI":"10.1183\/13993003.01618-2020"},{"key":"34145_CR7","doi-asserted-by":"publisher","first-page":"791348","DOI":"10.3389\/fimmu.2021.791348","volume":"12","author":"G Wang","year":"2021","unstructured":"Wang, G. et al. Presence of anti-MDA5 antibody and its value for the clinical assessment in patients with covid-19: a retrospective cohort study. Front Immunol. 12, 791348 (2021).","journal-title":"Front Immunol."},{"key":"34145_CR8","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1002\/art.41105","volume":"72","author":"H Tsuji","year":"2020","unstructured":"Tsuji, H. et al. Multicenter prospective study of the efficacy and safety of combined immunosuppressive therapy with high-dose glucocorticoid, tacrolimus, and cyclophosphamide in interstitial lung diseases accompanied by anti-melanoma differentiation-associated gene 5-positive dermatomyositis. Arthritis Rheumatol. 72, 488\u2013498 (2020).","journal-title":"Arthritis Rheumatol."},{"key":"34145_CR9","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1056\/NEJMc1900045","volume":"381","author":"Z Chen","year":"2019","unstructured":"Chen, Z., Wang, X. & Ye, S. Tofacitinib in amyopathic dermatomyositis-associated interstitial lung disease. N. Engl. J. Med. 381, 291\u2013293 (2019).","journal-title":"N. Engl. J. Med"},{"key":"34145_CR10","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1016\/j.chest.2020.04.057","volume":"158","author":"X Lian","year":"2020","unstructured":"Lian, X. et al. Mortality risk prediction in amyopathic dermatomyositis associated with interstitial lung disease: the flair model. Chest 158, 1535\u20131545 (2020).","journal-title":"Chest"},{"key":"34145_CR11","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1002\/art.21023","volume":"52","author":"S Sato","year":"2005","unstructured":"Sato, S. et al. Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis. Arthritis Rheum. 52, 1571\u20131576 (2005).","journal-title":"Arthritis Rheum."},{"key":"34145_CR12","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/bjd.14882","volume":"176","author":"T Matsushita","year":"2017","unstructured":"Matsushita, T. et al. Antimelanoma differentiation-associated protein 5 antibody level is a novel tool for monitoring disease activity in rapidly progressive interstitial lung disease with dermatomyositis. Br. J. Dermatol 176, 395\u2013402 (2017).","journal-title":"Br. J. Dermatol"},{"key":"34145_CR13","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1093\/rheumatology\/kes102","volume":"51","author":"T Gono","year":"2012","unstructured":"Gono, T. et al. Anti-MDA5 antibody, ferritin and IL-18 are useful for the evaluation of response to treatment in interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis. Rheumatol. (Oxf.) 51, 1563\u20131570 (2012).","journal-title":"Rheumatol. (Oxf.)"},{"key":"34145_CR14","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1007\/s00296-019-04398-2","volume":"39","author":"K Huang","year":"2019","unstructured":"Huang, K. et al. Clinical spectrum and therapeutics in Canadian patients with anti-melanoma differentiation-associated gene 5 (MDA5)-positive dermatomyositis: a case-based review. Rheumatol. Int 39, 1971\u20131981 (2019).","journal-title":"Rheumatol. Int"},{"key":"34145_CR15","doi-asserted-by":"publisher","first-page":"3343","DOI":"10.1093\/rheumatology\/keaa786","volume":"60","author":"A Xu","year":"2021","unstructured":"Xu, A. et al. Prognostic values of anti-Ro52 antibodies in anti-MDA5-positive clinically amyopathic dermatomyositis associated with interstitial lung disease. Rheumatol. (Oxf.) 60, 3343\u20133351 (2021).","journal-title":"Rheumatol. (Oxf.)"},{"key":"34145_CR16","doi-asserted-by":"publisher","first-page":"3909","DOI":"10.1007\/s00296-011-2323-y","volume":"32","author":"F Chen","year":"2012","unstructured":"Chen, F., Wang, D., Shu, X., Nakashima, R. & Wang, G. Anti-MDA5 antibody is associated with A\/SIP and decreased T cells in peripheral blood and predicts poor prognosis of ILD in Chinese patients with dermatomyositis. Rheumatol. Int. 32, 3909\u20133915 (2012).","journal-title":"Rheumatol. Int"},{"key":"34145_CR17","doi-asserted-by":"publisher","first-page":"3886","DOI":"10.1093\/rheumatology\/keaa266","volume":"59","author":"W Huang","year":"2020","unstructured":"Huang, W. et al. The characteristics of lymphocytes in patients positive for anti-MDA5 antibodies in interstitial lung disease. Rheumatol. (Oxf.) 59, 3886\u20133891 (2020).","journal-title":"Rheumatol. (Oxf.)"},{"key":"34145_CR18","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1093\/rheumatology\/key341","volume":"58","author":"K Wang","year":"2019","unstructured":"Wang, K. et al. CD4+CXCR4+ T cells as a novel prognostic biomarker in patients with idiopathic inflammatory myopathy-associated interstitial lung disease. Rheumatol. (Oxf.) 58, 511\u2013521 (2019).","journal-title":"Rheumatol. (Oxf.)"},{"key":"34145_CR19","doi-asserted-by":"publisher","first-page":"773352","DOI":"10.3389\/fimmu.2021.773352","volume":"12","author":"A Nombel","year":"2021","unstructured":"Nombel, A., Fabien, N. & Coutant, F. Dermatomyositis with anti-MDA5 antibodies: bioclinical features, pathogenesis and emerging therapies. Front Immunol. 12, 773352 (2021).","journal-title":"Front Immunol."},{"key":"34145_CR20","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/s41592-020-0748-5","volume":"17","author":"GW Schwartz","year":"2020","unstructured":"Schwartz, G. W. et al. TooManyCells identifies and visualizes relationships of single-cell clades. Nat. Methods 17, 405\u2013413 (2020).","journal-title":"Nat. Methods"},{"key":"34145_CR21","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s41586-018-0694-x","volume":"564","author":"L Zhang","year":"2018","unstructured":"Zhang, L. et al. Lineage tracking reveals dynamic relationships of T cells in colorectal cancer. Nature 564, 268\u2013272 (2018).","journal-title":"Nature"},{"key":"34145_CR22","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/s41586-019-1595-3","volume":"574","author":"RJM Bashford-Rogers","year":"2019","unstructured":"Bashford-Rogers, R. J. M. et al. Analysis of the B cell receptor repertoire in six immune-mediated diseases. Nature 574, 122\u2013126 (2019).","journal-title":"Nature"},{"key":"34145_CR23","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1016\/j.celrep.2018.07.093","volume":"24","author":"CT Ellebrecht","year":"2018","unstructured":"Ellebrecht, C. T. et al. Autoreactive IgG and IgA B cells evolve through distinct subclass switch pathways in the autoimmune disease pemphigus vulgaris. Cell Rep. 24, 2370\u20132380 (2018).","journal-title":"Cell Rep."},{"key":"34145_CR24","doi-asserted-by":"publisher","first-page":"e8370","DOI":"10.7717\/peerj.8370","volume":"8","author":"X Shi","year":"2020","unstructured":"Shi, X. et al. An analysis of abnormalities in the B cell receptor repertoire in patients with systemic sclerosis using high-throughput sequencing. PeerJ 8, e8370 (2020).","journal-title":"PeerJ"},{"key":"34145_CR25","doi-asserted-by":"publisher","first-page":"e134","DOI":"10.1093\/nar\/gks457","volume":"40","author":"G Yaari","year":"2012","unstructured":"Yaari, G., Uduman, M. & Kleinstein, S. H. Quantifying selection in high-throughput Immunoglobulin sequencing data sets. Nucleic Acids Res. 40, e134 (2012).","journal-title":"Nucleic Acids Res"},{"key":"34145_CR26","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/ni.3175","volume":"16","author":"CM Tipton","year":"2015","unstructured":"Tipton, C. M. et al. Diversity, cellular origin and autoreactivity of antibody-secreting cell population expansions in acute systemic lupus erythematosus. Nat. Immunol. 16, 755\u2013765 (2015).","journal-title":"Nat. Immunol."},{"key":"34145_CR27","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1136\/annrheumdis-2019-215442","volume":"78","author":"X Liu","year":"2019","unstructured":"Liu, X. et al. T cell receptor beta repertoires as novel diagnostic markers for systemic lupus erythematosus and rheumatoid arthritis. Ann. Rheum. Dis. 78, 1070\u20131078 (2019).","journal-title":"Ann. Rheum. Dis."},{"key":"34145_CR28","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1084\/jem.20050821","volume":"202","author":"GA Kolumam","year":"2005","unstructured":"Kolumam, G. A., Thomas, S., Thompson, L. J., Sprent, J. & Murali-Krishna, K. Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection. J. Exp. Med. 202, 637\u2013650 (2005).","journal-title":"J. Exp. Med"},{"key":"34145_CR29","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1038\/nmeth.4463","volume":"14","author":"S Aibar","year":"2017","unstructured":"Aibar, S. et al. SCENIC: single-cell regulatory network inference and clustering. Nat. Methods 14, 1083\u20131086 (2017).","journal-title":"Nat. Methods"},{"key":"34145_CR30","doi-asserted-by":"crossref","unstructured":"Wu, Y. et al. Spatiotemporal immune landscape of colorectal cancer liver metastasis at single-cell level. Cancer Discov. 12, 134\u2013153 (2021).","DOI":"10.1158\/2159-8290.CD-21-0316"},{"key":"34145_CR31","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1016\/j.immuni.2016.06.006","volume":"44","author":"D Wu","year":"2016","unstructured":"Wu, D. et al. Type I interferons induce changes in core metabolism that are critical for immune function. Immunity 44, 1325\u20131336 (2016).","journal-title":"Immunity"},{"key":"34145_CR32","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/s41556-018-0124-1","volume":"20","author":"JB Spinelli","year":"2018","unstructured":"Spinelli, J. B. & Haigis, M. C. The multifaceted contributions of mitochondria to cellular metabolism. Nat. Cell Biol. 20, 745\u2013754 (2018).","journal-title":"Nat. Cell Biol."},{"key":"34145_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-019-1906-x","volume":"21","author":"E Madissoon","year":"2019","unstructured":"Madissoon, E. et al. scRNA-seq assessment of the human lung, spleen, and esophagus tissue stability after cold preservation. Genome Biol. 21, 1 (2019).","journal-title":"Genome Biol."},{"key":"34145_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21246-9","volume":"12","author":"S Jin","year":"2021","unstructured":"Jin, S. et al. Inference and analysis of cell-cell communication using CellChat. Nat. Commun. 12, 1088 (2021).","journal-title":"Nat. Commun."},{"key":"34145_CR35","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1038\/s41596-020-0292-x","volume":"15","author":"M Efremova","year":"2020","unstructured":"Efremova, M., Vento-Tormo, M., Teichmann, S. A. & Vento-Tormo, R. CellPhoneDB: inferring cell-cell communication from combined expression of multi-subunit ligand-receptor complexes. Nat. Protoc. 15, 1484\u20131506 (2020).","journal-title":"Nat. Protoc."},{"key":"34145_CR36","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1136\/annrheumdis-2019-215208","volume":"78","author":"M Wu","year":"2019","unstructured":"Wu, M. et al. Interferon regulatory factor 7 (IRF7) represents a link between inflammation and fibrosis in the pathogenesis of systemic sclerosis. Ann. Rheum. Dis. 78, 1583\u20131591 (2019).","journal-title":"Ann. Rheum. Dis."},{"key":"34145_CR37","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1093\/rheumatology\/kex188","volume":"56","author":"Y Abe","year":"2017","unstructured":"Abe, Y. et al. Clinical characteristics and change in the antibody titres of patients with anti-MDA5 antibody-positive inflammatory myositis. Rheumatol. (Oxf.) 56, 1492\u20131497 (2017).","journal-title":"Rheumatol. (Oxf.)"},{"key":"34145_CR38","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1080\/14397595.2018.1548918","volume":"29","author":"A Nishioka","year":"2019","unstructured":"Nishioka, A. et al. Serum neopterin as well as ferritin, soluble interleukin-2 receptor, KL-6 and anti-MDA5 antibody titer provide markers of the response to therapy in patients with interstitial lung disease complicating anti-MDA5 antibody-positive dermatomyositis. Mod. Rheumatol. 29, 814\u2013820 (2019).","journal-title":"Mod. Rheumatol."},{"key":"34145_CR39","first-page":"204","volume":"30","author":"K Tokiyama","year":"1990","unstructured":"Tokiyama, K. et al. [Two cases of amyopathic dermatomyositis with fatal rapidly progressive interstitial pneumonitis]. Ryumachi 30, 204\u2013209 (1990).","journal-title":"Ryumachi"},{"key":"34145_CR40","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1002\/art.24621","volume":"60","author":"S Sato","year":"2009","unstructured":"Sato, S. et al. RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: association with rapidly progressive interstitial lung disease. Arthritis Rheum. 60, 2193\u20132200 (2009).","journal-title":"Arthritis Rheum."},{"key":"34145_CR41","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1007\/s10067-007-0562-9","volume":"26","author":"S Ye","year":"2007","unstructured":"Ye, S. et al. Adult clinically amyopathic dermatomyositis with rapid progressive interstitial lung disease: a retrospective cohort study. Clin. Rheumatol. 26, 1647\u20131654 (2007).","journal-title":"Clin. Rheumatol."},{"key":"34145_CR42","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s11926-018-0798-1","volume":"20","author":"S Moghadam-Kia","year":"2018","unstructured":"Moghadam-Kia, S., Oddis, C. V. & Aggarwal, R. Anti-MDA5 antibody spectrum in western world. Curr. Rheumatol. Rep. 20, 78 (2018).","journal-title":"Curr. Rheumatol. Rep."},{"key":"34145_CR43","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.1056\/NEJMcpc2107353","volume":"385","author":"ZS Wallace","year":"2021","unstructured":"Wallace, Z. S., Rodriguez, K., Dau, J., Bloch, D. B. & Champion, S. N. Case 37-2021: a 60-year-old man with fevers, fatigue, arthralgias, a mouth ulcer, and a rash. N. Engl. J. Med. 385, 2282\u20132293 (2021).","journal-title":"N. Engl. J. Med"},{"key":"34145_CR44","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1159\/000346573","volume":"225","author":"A Clottu","year":"2012","unstructured":"Clottu, A., Laffitte, E., Prins, C. & Chizzolini, C. Response of mucocutaneous lesions to rituximab in a case of melanoma differentiation antigen 5-related dermatomyositis. Dermatology 225, 376\u2013380 (2012).","journal-title":"Dermatology"},{"key":"34145_CR45","first-page":"5386797","volume":"2017","author":"Y Ogawa","year":"2017","unstructured":"Ogawa, Y., Kishida, D., Shimojima, Y., Hayashi, K. & Sekijima, Y. Effective administration of rituximab in anti-mda5 antibody-positive dermatomyositis with rapidly progressive interstitial lung disease and refractory cutaneous involvement: a case report and literature review. Case Rep. Rheumatol. 2017, 5386797 (2017).","journal-title":"Case Rep. Rheumatol."},{"key":"34145_CR46","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.2169\/internalmedicine.56.7956","volume":"56","author":"K Tokunaga","year":"2017","unstructured":"Tokunaga, K. & Hagino, N. Dermatomyositis with Rapidly Progressive Interstitial Lung Disease Treated with Rituximab: A Report of 3 Cases in Japan. Intern Med. 56, 1399\u20131403 (2017).","journal-title":"Intern Med"},{"key":"34145_CR47","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.1007\/s10067-020-05530-5","volume":"40","author":"Y Ge","year":"2021","unstructured":"Ge, Y. et al. Anti-melanoma differentiation-associated gene 5 (MDA5) antibody-positive dermatomyositis responds to rituximab therapy. Clin. Rheumatol. 40, 2311\u20132317 (2021).","journal-title":"Clin. Rheumatol."},{"key":"34145_CR48","doi-asserted-by":"publisher","first-page":"R214","DOI":"10.1186\/ar3547","volume":"13","author":"Y Muro","year":"2011","unstructured":"Muro, Y., Sugiura, K., Hoshino, K., Akiyama, M. & Tamakoshi, K. Epidemiologic study of clinically amyopathic dermatomyositis and anti-melanoma differentiation-associated gene 5 antibodies in central Japan. Arthritis Res. Ther. 13, R214 (2011).","journal-title":"Arthritis Res. Ther."},{"key":"34145_CR49","doi-asserted-by":"crossref","unstructured":"Nishina, N., Sato, S., Masui, K., Gono, T. & Kuwana, M. Seasonal and residential clustering at disease onset of anti-MDA5-associated interstitial lung disease. RMD Open 6, e001202 (2020).","DOI":"10.1136\/rmdopen-2020-001202"},{"key":"34145_CR50","doi-asserted-by":"publisher","first-page":"3736","DOI":"10.1002\/art.34657","volume":"64","author":"T Gono","year":"2012","unstructured":"Gono, T. et al. Brief report: association of HLA-DRB1*0101\/*0405 with susceptibility to anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis in the Japanese population. Arthritis Rheum. 64, 3736\u20133740 (2012).","journal-title":"Arthritis Rheum."},{"key":"34145_CR51","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.3899\/jrheum.170165","volume":"44","author":"Z Chen","year":"2017","unstructured":"Chen, Z. et al. HLA-DRB1 alleles as genetic risk factors for the development of anti-MDA5 antibodies in patients with dermatomyositis. J. Rheumatol. 44, 1389\u20131393 (2017).","journal-title":"J. Rheumatol."},{"key":"34145_CR52","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/j.1600-065X.2010.00926.x","volume":"236","author":"W Cui","year":"2010","unstructured":"Cui, W. & Kaech, S. M. Generation of effector CD8+ T cells and their conversion to memory T cells. Immunol. Rev. 236, 151\u2013166 (2010).","journal-title":"Immunol. Rev."},{"key":"34145_CR53","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1111\/imr.12424","volume":"272","author":"P van Endert","year":"2016","unstructured":"van Endert, P. Intracellular recycling and cross-presentation by MHC class I molecules. Immunol. Rev. 272, 80\u201396 (2016).","journal-title":"Immunol. Rev."},{"key":"34145_CR54","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1136\/annrheumdis-2017-212149","volume":"77","author":"Y Kochi","year":"2018","unstructured":"Kochi, Y. et al. Splicing variant of WDFY4 augments MDA5 signalling and the risk of clinically amyopathic dermatomyositis. Ann. Rheum. Dis. 77, 602\u2013611 (2018).","journal-title":"Ann. Rheum. Dis."},{"key":"34145_CR55","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1126\/science.aat5030","volume":"362","author":"DJ Theisen","year":"2018","unstructured":"Theisen, D. J. et al. WDFY4 is required for cross-presentation in response to viral and tumor antigens. Science 362, 694\u2013699 (2018).","journal-title":"Science"},{"key":"34145_CR56","first-page":"903","volume":"33","author":"M Funauchi","year":"2006","unstructured":"Funauchi, M. et al. Role of endothelial damage in the pathogenesis of interstitial pneumonitis in patients with polymyositis and dermatomyositis. J. Rheumatol. 33, 903\u2013906 (2006).","journal-title":"J. Rheumatol."},{"key":"34145_CR57","doi-asserted-by":"publisher","first-page":"151","DOI":"10.55563\/clinexprheumatol\/ubov8b","volume":"39","author":"C He","year":"2021","unstructured":"He, C., Chen, J., Luo, X. & Yan, B. Evaluation of biomarkers related to endothelial dysfunction: proof of vasculopathy in anti-melanoma differentiation-associated gene 5 dermatomyositis. Clin. Exp. Rheumatol. 39, 151\u2013157 (2021).","journal-title":"Clin. Exp. Rheumatol."},{"key":"34145_CR58","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1093\/rheumatology\/key386","volume":"58","author":"N Ono","year":"2019","unstructured":"Ono, N. et al. The relationship between type I IFN and vasculopathy in anti-MDA5 antibody-positive dermatomyositis patients. Rheumatol. (Oxf.) 58, 786\u2013791 (2019).","journal-title":"Rheumatol. (Oxf.)"},{"key":"34145_CR59","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.jid.2019.10.020","volume":"140","author":"C Cassius","year":"2020","unstructured":"Cassius, C. et al. MDA5(+) dermatomyositis is associated with stronger skin type I interferon transcriptomic signature with upregulation of IFN-kappa transcript. J. Invest Dermatol 140, 1276\u20131279 e1277 (2020).","journal-title":"J. Invest Dermatol"},{"key":"34145_CR60","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1016\/j.rmed.2015.07.004","volume":"109","author":"T Takada","year":"2015","unstructured":"Takada, T. et al. Serum cytokine profiles of patients with interstitial lung disease associated with anti-CADM-140\/MDA5 antibody positive amyopathic dermatomyositis. Respir. Med. 109, 1174\u20131180 (2015).","journal-title":"Respir. Med"},{"key":"34145_CR61","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/j.1365-2249.2012.04638.x","volume":"170","author":"M Nakano","year":"2012","unstructured":"Nakano, M. et al. Type I interferon induces CX3CL1 (fractalkine) and CCL5 (RANTES) production in human pulmonary vascular endothelial cells. Clin. Exp. Immunol. 170, 94\u2013100 (2012).","journal-title":"Clin. Exp. Immunol."},{"key":"34145_CR62","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S1074-7613(01)00126-1","volume":"14","author":"A Le Bon","year":"2001","unstructured":"Le Bon, A. et al. Type I interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo. Immunity 14, 461\u2013470 (2001).","journal-title":"Immunity"},{"key":"34145_CR63","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/S1074-7613(03)00208-5","volume":"19","author":"G Jego","year":"2003","unstructured":"Jego, G. et al. Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6. Immunity 19, 225\u2013234 (2003).","journal-title":"Immunity"},{"key":"34145_CR64","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1093\/rheumatology\/keu258","volume":"53","author":"T Gono","year":"2014","unstructured":"Gono, T. et al. Cytokine profiles in polymyositis and dermatomyositis complicated by rapidly progressive or chronic interstitial lung disease. Rheumatol. (Oxf.) 53, 2196\u20132203 (2014).","journal-title":"Rheumatol. (Oxf.)"},{"key":"34145_CR65","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1186\/s13075-018-1737-2","volume":"20","author":"Y Ishikawa","year":"2018","unstructured":"Ishikawa, Y. et al. Relevance of interferon-gamma in pathogenesis of life-threatening rapidly progressive interstitial lung disease in patients with dermatomyositis. Arthritis Res. Ther. 20, 240 (2018).","journal-title":"Arthritis Res. Ther."},{"key":"34145_CR66","doi-asserted-by":"publisher","first-page":"102831","DOI":"10.1016\/j.jaut.2022.102831","volume":"130","author":"F Coutant","year":"2022","unstructured":"Coutant, F., Bachet, R., Pin, J. J., Alonzo, M. & Miossec, P. Monoclonal antibodies from B cells of patients with anti-MDA5 antibody-positive dermatomyositis directly stimulate interferon gamma production. J. Autoimmun. 130, 102831 (2022).","journal-title":"J. Autoimmun."},{"key":"34145_CR67","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1006\/bbrc.2002.6487","volume":"291","author":"J Yamaoka","year":"2002","unstructured":"Yamaoka, J., Kabashima, K., Kawanishi, M., Toda, K. & Miyachi, Y. Cytotoxicity of IFN-gamma and TNF-alpha for vascular endothelial cell is mediated by nitric oxide. Biochem Biophys. Res. Commun. 291, 780\u2013786 (2002).","journal-title":"Biochem Biophys. Res. Commun."},{"key":"34145_CR68","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.trsl.2010.11.007","volume":"157","author":"T Isozaki","year":"2011","unstructured":"Isozaki, T. et al. Synergistic induction of CX3CL1 by interleukin-1beta and interferon-gamma in human lung fibroblasts: involvement of signal transducer and activator of transcription 1 signaling pathways. Transl. Res. 157, 64\u201370 (2011).","journal-title":"Transl. Res"},{"key":"34145_CR69","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/s43587-021-00067-x","volume":"1","author":"L Arthur","year":"2021","unstructured":"Arthur, L. et al. Cellular and plasma proteomic determinants of COVID-19 and non-COVID-19 pulmonary diseases relative to healthy aging. Nat. Aging 1, 535\u2013549 (2021).","journal-title":"Nat. Aging"},{"key":"34145_CR70","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/s41591-021-01329-2","volume":"27","author":"E Stephenson","year":"2021","unstructured":"Stephenson, E. et al. Single-cell multi-omics analysis of the immune response in COVID-19. Nat. Med. 27, 904\u2013916 (2021).","journal-title":"Nat. Med"},{"key":"34145_CR71","unstructured":"COMBAT. A blood atlas of COVID-19 defines hallmarks of disease severity and specificity. Cell 185, 916\u2013938 (2022)."},{"key":"34145_CR72","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1038\/s41590-020-00814-z","volume":"21","author":"MC Woodruff","year":"2020","unstructured":"Woodruff, M. C. et al. Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19. Nat. Immunol. 21, 1506\u20131516 (2020).","journal-title":"Nat. Immunol."},{"key":"34145_CR73","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1093\/rheumatology\/keg427","volume":"43","author":"DA Isenberg","year":"2004","unstructured":"Isenberg, D. A. et al. International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease. Rheumatol. (Oxf.) 43, 49\u201354 (2004).","journal-title":"Rheumatol. (Oxf.)"},{"key":"34145_CR74","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nbt.3192","volume":"33","author":"R Satija","year":"2015","unstructured":"Satija, R., Farrell, J. A., Gennert, D., Schier, A. F. & Regev, A. Spatial reconstruction of single-cell gene expression data. Nat. Biotechnol. 33, 495\u2013502 (2015).","journal-title":"Nat. Biotechnol."},{"key":"34145_CR75","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.cels.2019.03.003","volume":"8","author":"CS McGinnis","year":"2019","unstructured":"McGinnis, C. S., Murrow, L. M. & Gartner, Z. J. DoubletFinder: doublet detection in single-cell RNA sequencing data using artificial nearest neighbors. Cell Syst. 8, 329\u2013337(2019).","journal-title":"Cell Syst."},{"key":"34145_CR76","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","volume":"16","author":"I Korsunsky","year":"2019","unstructured":"Korsunsky, I. et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat. Methods 16, 1289\u20131296 (2019).","journal-title":"Nat. Methods"},{"key":"34145_CR77","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu, G., Wang, L. G., Han, Y. & He, Q. Y. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS 16, 284\u2013287 (2012).","journal-title":"OMICS"},{"key":"34145_CR78","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.cell.2016.03.008","volume":"165","author":"R Banchereau","year":"2016","unstructured":"Banchereau, R. et al. Personalized immunomonitoring uncovers molecular networks that stratify lupus patients. Cell 165, 551\u2013565 (2016).","journal-title":"Cell"},{"key":"34145_CR79","doi-asserted-by":"publisher","first-page":"627396","DOI":"10.3389\/fgene.2020.627396","volume":"11","author":"C Gu","year":"2020","unstructured":"Gu, C. et al. Identification of common genes and pathways in eight fibrosis diseases. Front Genet 11, 627396 (2020).","journal-title":"Front Genet"},{"key":"34145_CR80","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1158\/2159-8290.CD-21-0316","volume":"12","author":"Y Wu","year":"2022","unstructured":"Wu, Y. et al. Spatiotemporal immune landscape of colorectal cancer liver metastasis at single-cell level. Cancer Disco. 12, 134\u2013153 (2022).","journal-title":"Cancer Disco."},{"key":"34145_CR81","doi-asserted-by":"publisher","first-page":"3356","DOI":"10.1093\/bioinformatics\/btv359","volume":"31","author":"NT Gupta","year":"2015","unstructured":"Gupta, N. T. et al. Change-O: a toolkit for analyzing large-scale B cell immunoglobulin repertoire sequencing data. Bioinformatics 31, 3356\u20133358 (2015).","journal-title":"Bioinformatics"},{"key":"34145_CR82","doi-asserted-by":"publisher","first-page":"E862","DOI":"10.1073\/pnas.1417683112","volume":"112","author":"D Gadala-Maria","year":"2015","unstructured":"Gadala-Maria, D., Yaari, G., Uduman, M. & Kleinstein, S. H. Automated analysis of high-throughput B-cell sequencing data reveals a high frequency of novel immunoglobulin V gene segment alleles. Proc. Natl Acad. Sci. USA 112, E862\u2013E870 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"34145_CR83","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1016\/j.cell.2021.01.053","volume":"184","author":"X Ren","year":"2021","unstructured":"Ren, X. et al. COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas. Cell 184, 1895\u20131913(2021).","journal-title":"Cell"},{"key":"34145_CR84","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.it.2015.09.006","volume":"36","author":"V Greiff","year":"2015","unstructured":"Greiff, V., Miho, E., Menzel, U.& Reddy, S. T. Bioinformatic and Statistical Analysis of Adaptive Immune Repertoires. Trends Immunol. 36, 738\u2013749 (2015).","journal-title":"Trends Immunol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-34145-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-34145-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-34145-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,30]],"date-time":"2022-10-30T07:03:29Z","timestamp":1667113409000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-34145-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,29]]},"references-count":84,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["34145"],"URL":"https:\/\/doi.org\/10.1038\/s41467-022-34145-4","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,29]]},"assertion":[{"value":"19 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6458"}}